New Developments in the Treatment of Neuroendocrine Tumours – RADIANT-4, NETTER-1 and Telotristat Etiprate

European Endocrinology - United Kingdom
doi 10.17925/ee.2016.12.01.44
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Developments in the Treatment of Carcinoid Syndrome &Ndash; Impact of Telotristat

Therapeutics and Clinical Risk Management
2018English

Somatostatin Analogue Treatment of Neuroendocrine Tumours.

Postgraduate Medical Journal
Medicine
1996English

External Beam Radiotherapy in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Neglected Conditions: Neuroendocrine Tumours

CMAJ
Medicine
2014English

PWE-158 Thymosin Beta 4 as a Putative Marker in Neuroendocrine Tumours

Gut
Gastroenterology
2013English

CT/MRI of Neuroendocrine Tumours

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2006English

New Developments in the Diagnosis and Treatment of Thyroid Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
2013English

Molecular Imaging for Neuroendocrine Tumours

Swiss Medical Weekly
Medicine
2019English

PET/MRI in Neuroendocrine Tumours: Blessings and Curses

Current Radiopharmaceuticals
Nuclear MedicineRadiologyImagingPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy